From: Values, preferences and current hepatitis B and C testing practices in low- and middle-income countries: results of a survey of end users and implementers
Time point after end of treatment
Number of respondents (%)
4 weeks
19 (19.4%)
8 weeks
15 (15.3%)
12 weeks
43 (43.9%)
24 weeks
11 (11.2%)
No need for test of cure after DAA
1 (1%)
Total
98